Mitochondrial dysfunction in blood malignancies has been recently described and its involvement in tumorigenesis suggested. Association of mutations in mitochondrial DNA (mtDNA) and acute myeloid leukaemias (AMLs) has been warranting consideration because of recent reports showing the occurrence of somatic mtDNA mutations in a significant number of cases within cohorts of AML patients. 1, 2 The direct implication of mtDNA mutations in the pathogenesis of AMLs is still debated, 3 however, understanding the impact of mitochondrial dysfunction along with other cellular alterations might be of prognostic interest. 3 Acute megakaryoblastic leukaemia (AMegL) is a rare type of AML with severe prognosis 4 the incidence of which increases in Down's syndrome patients.
In the course of a study aimed to characterize mitochondrial respiratory activity of circulating blasts from patients affected by different French-American-British (FAB) Classification-defined AMLs, samples derived from an AMegL patient captured our attention because of distinctive features (summarized in Figure 1a ). The leukaemic cell samples were obtained from the patient's peripheral blood before therapeutic application. Purified CD34 þ haematopoietic stem/progenitor cells (HSPCs), isolated from healthy donors, were used as control. The endogenous respiratory activity, measured in intact AMegL cells, was higher than that observed in HSPCs (100±43 (n ¼ 3) vs 55 ± 8 pmol O 2 /min/10 6 cells (n ¼ 8); Po0.05) and was substantially depressed (82% inhibition) by added catalase (to an extent larger than that shown for the HSPCs). Addition of rotenone, a specific inhibitor of the mitochondrial respiratory chain, resulted, surprisingly, in stimulation of the endogenous O 2 consumption in AMegL cells ( þ 80%), whereas inhibited that of HSPCs (À60%). Of notice, catalase markedly abrogated the extra O 2 consumption induced by rotenone in AMegL cells.
Two-dimensional blue native/SDS PAGE analysis of proteins extracted from the inner mitochondrial membranes was performed to assess the subunit composition of the mitochondrial oxidative phosphorylation (OXPHOS) complexes (I-V). Compared with HSPCs, the AMegL cells revealed (i) quantitative decrease of the OXPHOS complexes-constituting subunits, (ii) the presence of not yet identified polypeptides and (iii) altered polypeptide 'spottings', indicative of changes in the assembly/ biogenesis of the complexes (See Supplementary Figure 1) .
As human mtDNA encodes for 13 polypeptides/subunits of the OXPHOS complexes, 5 we carried out a quantitative estimation of the mtDNA content. PCR amplicons of a fragment of the mtDNA, encompassed in a low frequency deletion zone, and of the 28S nuclear gene were used for calibrating the absolute amounts of the mitochondrial and nuclear genomic copy numbers in either HSPCs-CD34 þ and patient's AMegL-cells. The results obtained (Figure 1b) indicated that in AMegL-cells, the mtDNA copy number per cell unit was lower than that measured in normal HSPCs (314±15 vs 500±93, Po0.01 and confirmed by relative quantitative PCR using a different mtDNA primer pair).
Collectively analysing the results shown in Figure 1 , the higher endogenous cell respiration of AMegL cells, with respect to the HSPCs (Figure 1a ), would conflict with its reduced mtDNA copy number (Figure 1b) and amount of mitochondrial respiratory complexes. However, the observed effect of catalase reconciles the apparent discrepancy. Indeed, when considering the specific H 2 O 2 dismutase activity of catalase, its depressing effect on the oxygen uptake in both HSPC and AMegL cells clearly indicated that part of the endogenous oxygen consumption was linked to reactive oxygen species (ROS) production. In previous studies on human HSPCs, we showed that catalase completely abrogated the constitutive fluorescence signal of the H 2 O 2 -specific probe dichlorofluorescein (DCF). 6, 7 Thus, if the residual oxygen uptake, measured in the presence of catalase, is a better estimate of the contribution of the mitochondrial respiratory chain activity to the oxygen cell utilization then it can be concluded that it is lower in AMegL than in HSPCs in good agreement with both the reduced mitochondrial DNA content and respiratory chain protein expression. ROS generation in CD34 þ -HSPCs was unambiguously attributed to the constitutive activity of members of the NADPH-oxidase family. 7 However, this does not apply to the patient's AMegL cells in the present study because the catalase-sensitive overconsumption of O 2 elicited by rotenone on AMegL cells indicated a different ROS-generating source. As rotenone has been reported to induce ROS generation at the level of the NADH-ubiquinone oxidoreductase (complex I), 8 we further examined the case at the molecular level. Figure 2A illustrates the result obtained by sequencing the mtDNA from the patient's AMegL-cell samples. Multiple base changes and two insertions were found. Five base changes are single-nucleotide polymorphisms (SNPs) of which three have been already described (in the 12S and 16S rRNA genes and in the ND2) (Mitomap website: www.mitomap.org) and two are new SNPs falling in the cytochrome b (T15697C, Phe-Phe) and COXI (G6366A, Val4Ile) genes. The insertions and the four base changes are in the D-loop, controlling mtDNA replication. Mutations in this mtDNA hotspot have been described to occur in a number of solid tumours. 3 Interestingly, the mutations found here did not confer any replicative advantage to AMegL mitochondrial DNA (Figure 1c ) but, rather, some inhibitory effect different from what reported for other AMLs. 3 In addition, two missense mutations were found (G3316A, A3418G) in the ND1-encoding gene ( Figure 2B ). The G3316A mutation leading to A4T substitution has already been described in association with noninsulin dependent diabetes mellitus (NIDDM or Type II Diabetes) as well as Leber's hereditary optic neuropathy (LHON) and progressive external ophthalmoplegia (PEO) (Mitomap website). The A3418G mutation leading to N38D substitution has never been reported before and, thus, is a 'bona fide' new human disease-related mtDNA mutation. Of notice, the amplified fragment of the mtDNA encompassing the position of the two mutations in ND1 did not result in heteroduplex formation when subjected to the sensitive denaturating high performance liquid chromatography (DHPLC) test, whereas they formed that when mixed with the same fragment obtained from HSPC-mtDNA and assayed at the annealing temperatures specific for the two mutations (See Supplementary Figure 2) . This indicated that both mutations were homoplasmic. Mixing of the ND1 fragment obtained from HSPCs and from blast cells of other AML patients, FAB-typed as M0, M5b and M4, failed to detect heteroduplex formation (data not shown).
ND1 is a transmembrane subunit of the NADH-ubiquinone oxidoreductase (complex I) (Figure 3a) . The A4T substitution occurs at the NH 2 terminus of the first putative transmembrane helix, whereas the N38D substitution caused by the A3418G mutation falls in a loop connecting the first two putative transmembrane helices, which are exposed to the intramitochondrial space. This loop is predicted to contain two short alpha helices separated by an irregular secondary structure where the N38 residue is located (Figure 3a ). Sequence alignment with homologous ND1 subunits showed that N38 is invariant among the species analysed in a highly conserved 10-residues stretch (See Supplementary Figure 3) . Computational analysis of the N38D substitution resulted in negative DDG value for protein stability, indicating possible local conformational change upon mutation. Notably, in the same loop, an A52T substitution (mutation at nucleotide 3460) has been causally related to LHON and shown to result in change of the rotenone sensitivity and of the substrate affinity. Secondary structure prediction of transmembrane helix I-II-connecting loop of ND1 (26-65) in wild-type and N38D mutant is also shown. H, a-helix; S, strand; T, turn; C, coiled. Superscripts and subscripts refer to the wild-type and mutant, respectively. The difference in the energy stabilization between wild-type and N38D mutant as DDG is also shown (calculated by I-Mutant2.0). 8 (b) Schematic model showing the possible functional impact of the N38D substitution in the ND1 subunit of mitochondrial complex I. The ND1 subunit is shown in dark-grey in the membrane-associated arm of complex I with the helix I-II-connecting loop facing the intramitochondrial space. The ubiquinone substrate is also shown and the prevailing electron transfer to it from NADH through FMN and the N-2 iron-sulfur cluster is indicated by thick black arrows (other iron-sulphur centres were omitted for simplicity). In the N38D mutated ND1, the position of ubiquinone is displaced and as a consequence the electron transfer from N-2 is diverged to oxygen with formation of the superoxide anion O 2 KÀ ; SOD1/2, superoxide dismutases isoforms. See text for further details.
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Complex I catalyses the proton-pumping-coupled transfer of electrons from NADH to ubiquinone. 10 It is bigenomically made up by more than 40 subunits and ND1 is one of the seven (ND1 to ND7) mitochondrially encoded subunits. The function of ND1 is not unequivocally defined but a number of evidence support its involvement in rotenone and possibly ubiquinone binding. 10 The NADH-reducing equivalents are channelled through FMN along a path of Fe-S clusters with N2 being the last Fe-S centre before transfer to the ubiquinone acceptor. 10 It has long been recognized that complex I is a potential major source of O 2 KÀ , as result of electron leak directly to O 2 . Recent studies point to N2 as the main site of the electron detour.
11
Combining the functional/structural observations emerged from this study, we hypothesize that the mtDNA A3418G mutation found in the patient's AMegL cells causes a conformational change in the quinone-binding pocket of ND1, which affects the electron transfer to the substrate enhancing its deviation via N2 to O 2 ( Figure 3c ). This process would be further exacerbated by rotenone. The increased formation of O 2 KÀ leads to generation of the freely diffusible H 2 O 2 by the mitochondrial Mn-SOD.
To date, the limited number of studies available describes mainly heteroplasmic somatic mtDNA mutations in the more frequent cases of AML. [1] [2] [3] At the best of our knowledge, this is the first case of AMegL (M-7) for which a detailed functional and molecular analysis focused on the mitochondrial OXPHOS system is reported. The presence of mutations, of course, does not prove that they play a causative role in development of neoplastic lesions and progression; however, given the key role played by mitochondria in generation of DNA-damaging ROS, mtDNA mutations may provide or even elicit additional 'hits' contributing to tumour development. 12 Seventy-five percent of blasts present in the peripheral blood samples used in this study together with the cell immunophenotyping of the patient's bone marrow (that is, 99.2% CD45 þ , 83.1% CD13 þ , 495% GpIb þ ) unambiguously ruled out the occurrence of a mixture of hematopoietic and non-hematopoietic cell types, indicating that it was constituted by a homogeneous population of megakaryoblasts/megakaryocytes at different stages of maturation with the CD34 antigen expressed only on megakaryoblasts. The homoplasmic condition of the mtDNA mutations would, therefore, attain to the patient's HSPC reservoir. As the analyses described here were carried out on patient-postmortem blood samples, we cannot prove whether the mtDNA mutations found were inherited or somatically acquired. It cannot be excluded, however, that a small amount of mutated mtDNA was inherited and that this segregated progressively in the mesodermal-derived HSPC lineage, reaching therein the homoplasmic state. 13 mtDNA mutations might have remained silent in the hypoxic bone-marrow hematopoietic niche till additional mutational hits were acquired somewhere during the megakaryopoiesis pathway providing precursors with the ability of self-renewal as well as blastic proliferation.
In conclusion, the present study investigated, for the first time, the mithochondrial functional features and genome in circulating blasts of a patient affected by megacaryoblastic leukaemia. The results obtained provided evidence of abnormal ROS production in the patient's blasts, likely linked to constitutive alteration of the mitochondrial respiratory chain complex I as supported by the finding of homoplasmic mtDNA missense mutations in the ND1 gene.
